Gemcitabine 1000 mg
T5221
Phase 2 small_molecule active
Quick answer
Gemcitabine 1000 mg for Phase II, Open-label, Parallel 2-arm, Multi-center is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Phase II, Open-label, Parallel 2-arm, Multi-center
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active